MIAMI, March 17, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type…
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
VANCOUVER, British Columbia and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical…
Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
WAYNE, Pa., March 02, 2026 (GLOBE NEWSWIRE) — Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies…
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
BALA CYNWYD, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex…
Gaming and Leisure Properties Announces Pricing of $800,000,000 of 5.625% Senior Notes Due 2036
WYOMISSING, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (“GLPI”) (NASDAQ: GLPI) today announced the pricing of a public offering of…
MBody AI and Check Cap Ltd. ($MBAI) Submit Nasdaq Listing Application for Merger Close
Proposed Nasdaq-listed AI company achieves key regulatory milestone as merger with Check-Cap targets first half of 2026; $30M growth facility available. Source: MBody AI and…
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option Source: Eupraxia Pharmaceuticals Announces Closing of US.2 Million Public Offering…
Society Pass Incorporated Announces Pricing of $3.0 Million Public Offering of Common Stock
NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) — Society Pass Incorporated (Nasdaq: SOPA) (the “Company”), Southeast Asia’s (SEA) next generation e-commerce ecosystem, today announced the…
ARKO Corp. and ARKO Petroleum Corp. Announce Pricing of ARKO Petroleum Corp.’s Initial Public Offering
RICHMOND, Va., Feb. 11, 2026 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO) (“ARKO”) and ARKO Petroleum Corp., a subsidiary of ARKO (“APC”), today announced the…
SOLV Energy Announces Pricing of Initial Public Offering
SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) — SOLV Energy, Inc. (“SOLV” or the “Company”), a leading provider of infrastructure services to the power industry,…
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the closing of its previously announced underwritten public…
Agomab Announces Pricing of Initial Public Offering
Agomab today announced the pricing of its initial public offering of 12,500,000 ADSs representing 12,500,000 of its common shares. Source: Agomab Announces Pricing of Initial…
SpyGlass Pharma Announces Pricing of Initial Public Offering
ALISO VIEJO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the pricing of…
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
MILLBRAE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) — Eikon Therapeutics, Inc. (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing important, innovative medicines to address…
ARKO Corp. Announces Launch of Initial Public Offering of its Subsidiary, ARKO Petroleum Corp., Seeking to Raise Approximately $200,000,000
RICHMOND, Va., Feb. 03, 2026 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”) today announced that its subsidiary, ARKO Petroleum Corp. (“APC”),…
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”
PARAMUS, NJ, Feb. 02, 2026 (GLOBE NEWSWIRE) — Polaryx Therapeutics (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization…
Xsolla SPAC 1 Announces Closing of $200,000,000 Initial Public Offering
Sherman Oaks, CA, Jan. 30, 2026 (GLOBE NEWSWIRE) — Xsolla SPAC 1 (the “Company”), a newly organized special purpose acquisition company formed as a Cayman…
Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock
GAITHERSBURG, Md., Jan. 29, 2026 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, announced…
Ethos Announces Pricing of Initial Public Offering
Ethos Announces Pricing of Initial Public Offering Source: Ethos Announces Pricing of Initial Public Offering
Comstock Inc. Prices $50 Million Upsized and Oversubscribed Public Offering of Common Stock
VIRGINIA CITY, Nev., Jan. 28, 2026 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”), today announced that it has priced its previously…